MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 21, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions
StrokeStroke, IschemicStrokes ThromboticStroke SequelaeStroke, CardiovascularStroke, EmbolicStroke, Cryptogenic
Interventions
OTHER

Placebo

Caramel, chocolate brown, flavor (E\_1982648), dextrin

DRUG

MLC1501

Powdered extract of Radix astragali, Rhizoma chuanxiong, Radix angelica sinensis, Radix polygala

Trial Locations (11)

Unknown

Metro Davao Medical And Research Center, Davao City

Quirino Memorial Medical Center, Manila

University of Santo Tomas Hospital, Manila

Baguio General Hospital and Medical Center, Baguio City

West Visayas State University Medical Center, Iloilo City

Jose R. Reyes Memorial Medical Center, Manila

Manila Doctors Hospita, Manila

Changi General Hospital, Singapore

National Neuroscience Institute (NNI) @ Tan Tock Seng Hospital (TTSH), Singapore

Raffles Hospital, Singapore

Singapore General Hospital, Singapore

All Listed Sponsors
lead

Moleac Pte Ltd.

INDUSTRY